Ampio Strengthens Patent Protection for Lead Drug Ampion

Loading...
Loading...
Ampio Pharmaceuticals, Inc.
AMPE
today announced that it has received notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion™.
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...